RecruitingNot Applicable

Liver Transplant CGM

United States40 participantsStarted 2025-10-13

Plain-language summary

This investigator initiated study aims to describe continuous glucose monitoring (CGM) based glycemic metrics after discharge from liver transplant and assess relationship with glycemic metrics and liver transplant outcomes.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: • inpatient liver transplant participants who have had an inpatient glucose greater than 180mg/dL Exclusion Criteria: * having a planned discharge to a rehabilitation or nursing facility, * a contraindication to sensor placement, * if discharge is anticipated to be \>30 days post-transplant, or * if recent transplant also included a kidney or pancreas transplant

What they're measuring

Time in range

Timeframe: 28 days

Trial details

NCT IDNCT07216508

SponsorIcahn School of Medicine at Mount Sinai

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-10-05

Contact for this trial

Grenye O'Malley

212-241-7173 grenye.o'malley@mssm.edu

View on ClinicalTrials.gov More Liver Transplant trials